BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  IN PARTNERSHIP WITH PTP

  Webinar: Data Lakes & FAIR Principles: Making Scientific Data Accessible and Actionable

  In this discussion, our guests explore how modern data lake architectures, built on AWS, can help your organization adopt FAIR data principles—Findable, Accessible, Interoperable, and Reusable—to unlock the full potential of your scientific data.
  

  September 24, 2025

   · 

  1 min read

   · 

  BioSpace Insights
• Press Releases

  NorthStar Medical Radioisotopes, LLC and University of Wisconsin School of Medicine and Public Health Enter Strategic Partnership to Advance Radiopharmaceutical Research, Innovation and Talent Development

  September 24, 2025

   · 

  4 min read
• Press Releases

  Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts

  September 24, 2025

   · 

  3 min read
• Press Releases

  Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate Cardiomyocytes to Advance Cardiac Safety Research

  September 24, 2025

   · 

  2 min read
• Press Releases

  Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients

  September 24, 2025

   · 

  4 min read
• Press Releases

  Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

  September 24, 2025

   · 

  5 min read
• Press Releases

  Actio Biosciences Announces First Participant Dosed in Phase 1 Clinical Trial of ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy

  September 24, 2025

   · 

  3 min read
• Press Releases

  Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Semnur Common Stock in Exchange for $100 Million in Bitcoin

  September 24, 2025

   · 

  9 min read
• Press Releases

  Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

  September 24, 2025

   · 

  10 min read
• Press Releases

  Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease

  September 24, 2025

   · 

  5 min read